Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

News Coverage

Another Needle-Free Epinephrine Option Moves Closer to FDA Review

FASI Celebrates 10 Years with $10 Million Push for New Food Allergy Medicines

Study Finds Gut Barrier Defects May Predispose People to Peanut Allergy

Study Finds Eczema Drug Dupilumab Drives Down Food Allergy IgE but Increases Reactions

DBV Submits VIASKIN Peanut Patch for FDA Approval Following Phase 3 Success

Aimmune Warns Coronavirus Will Slow Marketing of Palforzia Treatment for Peanut...

FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...

Biphasic Anaphylaxis is Difficult to Predict, Can Occur Much Later Than...

Study: Intranasal Epinephrine Absorbed Faster Than Injection and Even Better with...

Pizza Chain Topping Their Special Pie with Peanut Shells is Endangering...

Study: How Potent Are Epinephrine Auto-Injectors After the Expiration Date?

Coronavirus Resources from the National Association of School Nurses

AAAAI Cancels 2020 Annual Meeting

UK Issues Recall of Emerade 150µg Epinephrine Auto-Injectors

Study: Cesarean Birth Has Little Impact on Children Developing Allergies

Follow Us

Your School On Our Map

Put Your School on the Map